[
    [
        {
            "time": "2020-06-11",
            "original_text": "Coronavirus update: US reopening dogged by fears of new wave as pharma presses on with vaccine",
            "features": {
                "keywords": [
                    "Coronavirus",
                    "US",
                    "reopening",
                    "fears",
                    "pharma",
                    "vaccine"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Coronavirus update: US reopening dogged by fears of new wave as pharma presses on with vaccine",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-06-11",
            "original_text": "AbbVie Inks Deal With Genmab, Announces ADC Candidate Data",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Genmab",
                    "ADC",
                    "Candidate",
                    "Data"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie Inks Deal With Genmab, Announces ADC Candidate Data",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-11",
            "original_text": "Regeneron Begins Human Trials of a Potential COVID-19 Treatment",
            "features": {
                "keywords": [
                    "Regeneron",
                    "Human",
                    "Trials",
                    "COVID-19",
                    "Treatment"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Regeneron Begins Human Trials of a Potential COVID-19 Treatment",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-06-11",
            "original_text": "Company News for Jun 11, 2020",
            "features": {
                "keywords": [
                    "Company",
                    "News"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Company News for Jun 11, 2020",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 3,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-11",
            "original_text": "Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist",
            "features": {
                "keywords": [
                    "Lilly",
                    "COVID-19",
                    "treatment",
                    "authorized",
                    "September",
                    "chief",
                    "scientist"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Exclusive: Lilly COVID-19 treatment could be authorized for use as soon as September - chief scientist",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]